Artificial Intelligence for Automated Quality Assurance in RadioTherapy for glioblastoma target volume and organs at risk delineation in clinical trials - AQUA RT
Gruppe Reyes In this project we aim to test the hypothesis that AI-based auto-segmentation technologies can be used for an AI-assisted multi-criteria quality assurance assessment in radiation therapy. The proposed multicriteria evaluation model is expected to provide a more objective review than traditional approaches, while at the same time focussing on clinically relevant radiotherapy aspects. The proposed Automated QUality Assurance in RadioTherapy (AQUA-RT) framework has the potential to increase consistency, improve delineation quality and reduce workload for routinely challenging quality assurance procedures.
Easy and accurate quantification of mutational signatures in cancer samples
Group Zimmer, Medo Mutations in the genome are often not random but follow distinct patterns. These patterns, termed mutational signatures, are footprints of biological processes or past exposures to specific carcinogens. Mutational signatures can help to elucidate tumor evolution and have prognostic and therapeutic implications.
Mathematical estimation of signature activities is a high-dimensional statistical problem. Although many tools for signature analysis have been developed, a recent analysis showed that no tool performs best under all conditions.
We propose to identify the best-performing tool for a given task, cancer type, and number of mutations. This will be achieved by extensive prior testing of the existing tools on synthetic data under different conditions. We further propose to design a new tool that will explicitly include mutations that are not well explained by any known signature.
With the two proposed tools, we aim to optimally use costly sequencing data and produce informed decisions for patient treatments.